Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2018 Filed Dec 12, 2018 22:27 UTC |
Schuth Alexander O.COO and Secretary
|
SaleCommon Stock | 2,500 | $20.22 | $50,550.00 |
DisclosureSEC source: 0001209191-18-062266 · doc4.xml · nonDerivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 680,089 F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.90 to $20.59 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F4 · ownership.nature: The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:27 UTC |
Schuth Alexander O.COO and Secretary
|
SaleCommon Stock | 2,500 | $20.18 | $50,450.00 |
DisclosureSEC source: 0001209191-18-062266 · doc4.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 682,589 F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.74 to $20.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F4 · ownership.nature: The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:06 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 400 | $19.16 | $7,664.00 |
DisclosureSEC source: 0001209191-18-061329 · doc4.xml · nonDerivative · entry 4 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,670,971 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.15 to $19.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:06 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 17,933 | $18.42 | $330,273.85 |
DisclosureSEC source: 0001209191-18-061329 · doc4.xml · nonDerivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,671,371 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.05 to $18.86 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:08 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 400 | $19.16 | $7,664.00 |
DisclosureSEC source: 0001209191-18-061334 · doc4.xml · nonDerivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 148,390 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.15 to $19.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:08 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,100 | $18.43 | $315,170.10 |
DisclosureSEC source: 0001209191-18-061334 · doc4.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 148,790 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.07 to $18.87 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Nov 30, 2020 23:13 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-20-060791 · doc4a.xml · derivative · entry 6 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,375 Underlying: Common Stock · 17,500 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| December 03, 2018 Filed Nov 30, 2020 23:13 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 400 | $19.16 | $7,664.00 |
DisclosureSEC source: 0001209191-20-060791 · doc4a.xml · nonDerivative · entry 5 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,125 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.15 to $19.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Nov 30, 2020 23:13 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,100 | $18.43 | $315,170.10 |
DisclosureSEC source: 0001209191-20-060791 · doc4a.xml · nonDerivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,525 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.07 to $18.87 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| December 03, 2018 Filed Nov 30, 2020 23:13 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 17,500 | $5.28 | $92,400.00 |
DisclosureSEC source: 0001209191-20-060791 · doc4a.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 195,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| November 27, 2018 Filed Dec 6, 2018 22:06 UTC |
Watts Ryan J.Director · President and CEO
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061329 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,689,304 F1 · kind: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| November 15, 2018 Filed Nov 15, 2018 23:13 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 13,588 | $18.12 | $246,236.30 |
DisclosureSEC source: 0001209191-18-058797 · doc4.xml · nonDerivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,729,304 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.49 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 22:31 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,500 | $18.07 | $316,156.75 |
DisclosureSEC source: 0001209191-18-059267 · doc4.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 165,890 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| November 15, 2018 Filed Nov 30, 2020 23:12 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,235 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-20-060790 · doc4a.xml · derivative · entry 5 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,875 Underlying: Common Stock · 12,235 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| November 15, 2018 Filed Nov 30, 2020 23:12 UTC Amendment |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,500 | $18.07 | $316,156.75 |
DisclosureSEC source: 0001209191-20-060790 · doc4a.xml · nonDerivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,125 F4 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| November 15, 2018 Filed Nov 30, 2020 23:12 UTC Amendment |
Ho CaroleChief Medical Officer
|
Exercise / conversionCommon Stock | 12,235 | $5.28 | $64,600.80 |
DisclosureSEC source: 0001209191-20-060790 · doc4a.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 195,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 23:13 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 4,746 | $18.00 | $85,428.00 |
DisclosureSEC source: 0001209191-18-058797 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,742,892 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 22:37 UTC |
Cook Jennifer E.Director
|
GrantStock Option (right to buy) · Derivative | 50,044 | $0.00 Strike: $17.08 | $0.00 |
DisclosureSEC source: 0001209191-18-057789 · doc4.xml · derivative · entry 1 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,044 Underlying: Common Stock · 50,044 shares Expires 2028-11-05 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on November 6, 2019, and an additional 1/48 of the shares subject to the option vest each month thereafter. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 21:58 UTC |
Schuth Alexander O.COO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,859 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001209191-18-054042 · doc4.xml · derivative · entry 5 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,641 Underlying: Common Stock · 5,859 shares Expires 2027-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on August 22, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 21:58 UTC |
Schuth Alexander O.COO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,184 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-18-054042 · doc4.xml · derivative · entry 4 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,898 Underlying: Common Stock · 1,184 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 21:58 UTC |
Schuth Alexander O.COO and Secretary
|
Exercise / conversionCommon Stock | 5,859 | $9.60 | $56,246.40 |
DisclosureSEC source: 0001209191-18-054042 · doc4.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 21:58 UTC |
Schuth Alexander O.COO and Secretary
|
Exercise / conversionCommon Stock | 1,184 | $5.28 | $6,251.52 |
DisclosureSEC source: 0001209191-18-054042 · doc4.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 22:01 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 18,333 | $21.72 | $398,192.76 |
DisclosureSEC source: 0001209191-18-054056 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,747,638 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $21.36 to $22.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:59 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,500 | $21.72 | $380,100.00 |
DisclosureSEC source: 0001209191-18-054050 · doc4.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 183,390 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $21.36 to $22.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 21:25 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 18,333 | $19.06 | $349,426.98 |
DisclosureSEC source: 0001209191-18-049906 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,765,971 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.65 to $19.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 21:27 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,500 | $19.05 | $333,375.00 |
DisclosureSEC source: 0001209191-18-049912 · doc4.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 200,890 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.65 to $19.51 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:41 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 18,334 | $18.05 | $330,928.70 |
DisclosureSEC source: 0001209191-18-049118 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,784,304 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:44 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 17,500 | $18.04 | $315,700.00 |
DisclosureSEC source: 0001209191-18-049119 · doc4.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 218,390 F3 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.00 to $18.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F5 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:45 UTC |
Schuth Alexander O.COO and Secretary
|
GrantRestricted Stock Units · Derivative | 11,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048030 · doc4.xml · derivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,286 Underlying: Common Stock · 11,286 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: 50% of the restricted stock units shall vest on August 20, 2019 and the remaining 50% shall vest on August 20, 2020, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · derivative.expiration_date: 50% of the restricted stock units shall vest on August 20, 2019 and the remaining 50% shall vest on August 20, 2020, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:43 UTC |
Ho CaroleChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 11,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048028 · doc4.xml · derivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,286 Underlying: Common Stock · 11,286 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: 50% of the restricted stock units shall vest on August 20, 2019 and the remaining 50% shall vest on August 20, 2020, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · derivative.expiration_date: 50% of the restricted stock units shall vest on August 20, 2019 and the remaining 50% shall vest on August 20, 2020, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:42 UTC |
Krognes Steve E.CFO and Treasurer
|
GrantRestricted Stock Units · Derivative | 11,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048025 · doc4.xml · derivative · entry 1 Krognes Steve E. · CIK 0001666236 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,286 Underlying: Common Stock · 11,286 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: 50% of the restricted stock units shall vest on August 20, 2019 and the remaining 50% shall vest on August 20, 2020, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · derivative.expiration_date: 50% of the restricted stock units shall vest on August 20, 2019 and the remaining 50% shall vest on August 20, 2020, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 21:38 UTC |
Schuth Alexander O.COO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,918 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001209191-18-039531 · doc4.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,082 Underlying: Common Stock · 5,918 shares Expires 2027-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 21:38 UTC |
Schuth Alexander O.COO and Secretary
|
Exercise / conversionCommon Stock | 5,918 | $5.28 | $31,247.04 |
DisclosureSEC source: 0001209191-18-039531 · doc4.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 22:31 UTC |
NELSEN ROBERTDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 27,830 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001209191-18-038159 · doc4.xml · derivative · entry 1 NELSEN ROBERT · CIK 0001219042 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Underlying: Common Stock · 27,830 shares Expires 2028-06-12 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 22:30 UTC |
Tessier-Lavigne MarcDirector
|
GrantStock Option (right to buy) · Derivative | 27,830 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001209191-18-038158 · doc4.xml · derivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Underlying: Common Stock · 27,830 shares Expires 2028-06-12 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 22:29 UTC |
FLATLEY JAY TDirector
|
GrantStock Option (right to buy) · Derivative | 27,830 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001209191-18-038157 · doc4.xml · derivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Underlying: Common Stock · 27,830 shares Expires 2028-06-12 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 22:28 UTC |
Schenkein David PDirector
|
GrantStock Option (right to buy) · Derivative | 27,830 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001209191-18-038156 · doc4.xml · derivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Underlying: Common Stock · 27,830 shares Expires 2028-06-12 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 22:27 UTC |
Cole Douglas G.Director
|
GrantStock Option (right to buy) · Derivative | 27,830 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001209191-18-038154 · doc4.xml · derivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Underlying: Common Stock · 27,830 shares Expires 2028-06-12 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 22:27 UTC |
SATO VICKI LDirector
|
GrantStock Option (right to buy) · Derivative | 27,830 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001209191-18-038152 · doc4.xml · derivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Underlying: Common Stock · 27,830 shares Expires 2028-06-12 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, in each case, provided that the Reporting Person continues to serve as a non-employee director through the applicable vesting date. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 22:29 UTC |
Klein Peter SDirector
|
GrantStock Option (right to buy) · Derivative | 37,954 | $0.00 Strike: $21.54 | $0.00 |
DisclosureSEC source: 0001209191-18-020968 · doc4.xml · derivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,954 Underlying: Common Stock · 37,954 shares Expires 2028-03-15 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on March 16, 2019 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:53 UTC |
Watts Ryan J.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $22.16 | $0.00 |
DisclosureSEC source: 0001209191-18-014727 · doc4.xml · derivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-02-25 F2 · derivative.exercise_date: 25% of the shares subject to the option will vest on February 26, 2019 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:55 UTC |
Schuth Alexander O.COO and Secretary
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $22.16 | $0.00 |
DisclosureSEC source: 0001209191-18-014728 · doc4.xml · derivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2028-02-25 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on February 26, 2019 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:57 UTC |
Ho CaroleChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $22.16 | $0.00 |
DisclosureSEC source: 0001209191-18-014731 · doc4.xml · derivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2028-02-25 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on February 26, 2019 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:56 UTC |
Krognes Steve E.CFO and Treasurer
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $22.16 | $0.00 |
DisclosureSEC source: 0001209191-18-014730 · doc4.xml · derivative · entry 1 Krognes Steve E. · CIK 0001666236 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2028-02-25 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on February 26, 2019 and an additional 1/48 of the shares vest monthly thereafter. Read SEC document |
| December 13, 2017 Filed Mar 1, 2018 00:53 UTC |
Watts Ryan J.Director · President and CEO
|
GrantCommon Stock | 5 | $20.47 | $102.35 |
DisclosureSEC source: 0001209191-18-014727 · doc4.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,505 Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 22:34 UTC |
Watts Ryan J.Director · President and CEO
|
ConversionSeries B-1 Preferred Stock · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065240 · doc4.xml · derivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.exercise_date: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 22:34 UTC |
Watts Ryan J.Director · President and CEO
|
ConversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-065240 · doc4.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 22:52 UTC |
Flagship Ventures Fund V, L.P.10% owner
Afeyan Noubar10% owner
|
ConversionSeries B-1 Preferred Stock · Derivative | 156,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065253 · doc4.xml · derivative · entry 4 Flagship Ventures Fund V, L.P. · CIK 0001627639 · 10% owner AFEYAN NOUBAR · CIK 0001222012 · 10% owner Flagship Ventures Fund V General Partner LLC · CIK 0001724575 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 156,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F3 · derivative.exercise_date: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F3 · derivative.expiration_date: The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · ownership.direct: Held by Flagship Ventures Fund V, L.P. ("Flagship V"). Flagship Ventures Fund V General Partner LLC ("Flagship V LLC") is the general partner of Flagship V. Noubar B. Afeyan, Ph.D. is the manager of Flagship V LLC. Flagship V LLC and Dr. Afeyan may be deemed to possess voting and investment control over all shares held by Flagship V. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 22:52 UTC |
Flagship Ventures Fund V, L.P.10% owner
Afeyan Noubar10% owner
|
ConversionSeries A-2 Preferred Stock · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065253 · doc4.xml · derivative · entry 3 Flagship Ventures Fund V, L.P. · CIK 0001627639 · 10% owner AFEYAN NOUBAR · CIK 0001222012 · 10% owner Flagship Ventures Fund V General Partner LLC · CIK 0001724575 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series A-2 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · derivative.exercise_date: The Series A-2 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F2 · derivative.expiration_date: The Series A-2 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · ownership.direct: Held by Flagship Ventures Fund V, L.P. ("Flagship V"). Flagship Ventures Fund V General Partner LLC ("Flagship V LLC") is the general partner of Flagship V. Noubar B. Afeyan, Ph.D. is the manager of Flagship V LLC. Flagship V LLC and Dr. Afeyan may be deemed to possess voting and investment control over all shares held by Flagship V. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 22:52 UTC |
Flagship Ventures Fund V, L.P.10% owner
Afeyan Noubar10% owner
|
ConversionSeries A-1 Preferred Stock · Derivative | 8,324,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065253 · doc4.xml · derivative · entry 2 Flagship Ventures Fund V, L.P. · CIK 0001627639 · 10% owner AFEYAN NOUBAR · CIK 0001222012 · 10% owner Flagship Ventures Fund V General Partner LLC · CIK 0001724575 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,324,999 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.exercise_date: The Series A-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series A-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. F4 · ownership.direct: Held by Flagship Ventures Fund V, L.P. ("Flagship V"). Flagship Ventures Fund V General Partner LLC ("Flagship V LLC") is the general partner of Flagship V. Noubar B. Afeyan, Ph.D. is the manager of Flagship V LLC. Flagship V LLC and Dr. Afeyan may be deemed to possess voting and investment control over all shares held by Flagship V. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.